Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICULIP: Lipid Emulsions and Nosocomial Infection in Critical Patients
NCT00396461Phase 4Terminated
- Sponsor
- B. Braun
- Start
- Nov 2006
- Primary completion
- Sep 2010
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lipidem in nosocomial infection (2 arms), sponsored by B. Braun. Primary endpoint: Incidence of nosocomial infection at 28 days. Started Nov 2006; status: terminated.
02
Drugs
Lipidem
03
Conditions
nosocomial infection
Beyond the preview
Go deeper on NCT00396461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396461.